Limited efficacy of targeted treatments in Sjogren's syndrome: why?

被引：0
|
作者：
Tzioufas, A. G. [1 ]
Goules, A. V. [1 ]
机构：
[1] Athens Sch Med, Dept Pathophysiol, Athens, Greece
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2018年 / 36卷 / 03期
关键词：
Sjogren's syndrome; targeted treatments; efficacy; TNF;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S27 / S28
页数：2
相关论文
共 50 条
  • [1] Future treatments for Sjogren's syndrome
    Pers, Jacques-Olivier
    Saraux, Alain
    PRESSE MEDICALE, 2016, 45 (06): : E193 - E200
  • [2] Current treatments of xerophthalmia in Sjogren's syndrome
    Baudouin, C
    Pisella, PJ
    Brignole, F
    REVUE DE MEDECINE INTERNE, 2004, 25 (05): : 376 - 382
  • [3] Safety of treatments for primary Sjogren's syndrome
    van Nimwegen, Jolien F.
    Moerman, Rada V.
    Smitt, Nicole Sillevis
    Brouwer, Elisabeth
    Bootsma, Hendrika
    Vissink, Arjan
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (04) : 513 - 524
  • [4] Sjogren's syndrome: Why autoimmune epithelitis?
    Mitsias, D. I.
    Kapsogeorgou, E. K.
    Moutsopoulos, H. M.
    ORAL DISEASES, 2006, 12 (06) : 523 - 532
  • [5] What is Sjogren's syndrome and why is it important?
    Talal, N
    JOURNAL OF RHEUMATOLOGY, 2000, 27 : 1 - 3
  • [6] Current and potential treatments for primary Sjogren's syndrome
    Mariette, X
    JOINT BONE SPINE, 2002, 69 (04) : 363 - 366
  • [7] Why stratification is important in primary Sjogren's syndrome
    Lendrem, D. W.
    Tarn, J. R.
    Collins, A.
    Wason, J.
    Ng, W. F.
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (09) : 1661 - 1662
  • [8] Sjogren's syndrome patient preferences for xerostomia treatments.
    Vivino, FB
    Shore, JB
    Huang, CH
    May, RM
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 220 - 220
  • [9] Why do drug treatments fail in Sjogren's disease? Considerations for treatment, trial design and interpretation of clinical efficacy
    Arends, Suzanne
    Verstappen, Gwenny M. M.
    de Wolff, Liseth
    Pringle, Sarah
    Kroese, Frans G. M.
    Vissink, Arjan
    Bootsma, Hendrika
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (10) : 1187 - 1194
  • [10] B cell-targeted therapies in Sjogren's syndrome
    Tobon, Gabriel J.
    Pers, Jacques Olivier
    Youinou, Pierre
    Saraux, Alain
    AUTOIMMUNITY REVIEWS, 2010, 9 (04) : 224 - 228
12345